Successful online workshop connects underrepresented European countries in rare disease research

Underrepresented countries help shape ERDERA’s roadmap for a more inclusive European rare disease research ecosystem

online workshop

On 20-21 November the workshop “Networking of Underrepresented Countries for the Enhancement of Rare Disease Research” was held by ERDERA, bringing together 157 participants from 25 underrepresented countries, including Widening and Associated Countries. Their participation was a key element of the event, emphasizing the importance of ensuring that national perspectives with historically limited representation in EU-level initiatives are fully included in shaping the future of rare disease research.

Participants from these countries contributed valuable inputs on capacity gaps, structural barriers, and priority needs – insights that are essential for building a more inclusive and equitable European rare disease ecosystem.

The workshop gathered stakeholders from across the rare disease multi-stakeholder community, including healthcare professionals, researchers, patient organizations, and funding bodies. Throughout the parallel sessions, facilitated by the MIRO tool, participants engaged in discussions, shared national experiences, and identified practical approaches to strengthen research infrastructures, networking, and collaboration. The diversity of voices ensured that the workshop outputs reflect the realities and ambitions of underrepresented countries.

This event represents an important step toward ensuring inclusive participation, visibility, and cooperation across Europe. The input collected will guide ERDERA’s upcoming activities as we continue working together to support a more connected and balanced rare disease research landscape.

News & Updates

You might also be interested in

ERDERA joins the Wilhelm Foundation and the Gdansk Medical University and Clinical Centre to strengthen phenotype‑led diagnosis for people living with undiagnosed conditions
Taking place at a pivotal moment – with the European Rare Disease Plan expected to move forward significantly during 2026 – the meetings brought together National Mirror Group (NMG) representatives from Europe and beyond, alongside European Commission stakeholders, IRDiRC and international partners.
A legislative own initiative file in the Parliament’s new public health committee sets out what an EU “rare disease action framework” could look like — and why it could change how Europe measures progress for patients.